Exit Strategies: Beginning with the End in Mind
Recent U.S. tax cuts and the growth of available capital has kept the spotlight focused on M&A in almost every industry, including medical technology. Although 2018 has not seen the multi-billion-dollar blockbuster deals of recent years (i.e., Medtronic–Covidien, Zimmer–Biomet, BD–Bard, Abbott–St. Jude Medical Inc.
Exit Strategy for Emerging Technologies - Working with the The Big "S"
If you are seeking a possible exit with a “Big S” (Fortune 500 Multi-National Company “MNC”), there are some key factors for you to consider which may vary slightly from an exit for a P.E. or for IPO.
Contact us.
We love what we do as we partner with our clients to bring them success. There are often many approaches to achieve your goals and will help you be successful. The best thing about our services is that YOU decide what YOU want to engage us for.
Connect with us for further details.
contact@medworldadvisors.com
(805) 441-0962
153 Summer Street
Andover, MA 01810